Brief: Harris and Harris says Enumeral Biomedical's collaboration with Merck
22/12/2014 17:29
Dec 22 (Reuters) - Harris and Harris Group Inc TINY.O : * Harris & Harris Group notes publicly traded portfolio company Enumeral Biomedical's collaboration with Merck * Enumeral to receive research and development funding,is eligible to receive undisclosed future milestone payments if certain goals are achieved * Merck has exclusive rights to data related to proprietary compounds that are generated from the studies * Source text for Eikon ID:nGNXVCJLRa * Further company coverage TINY.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on 180 Degree Capital
See all newsBrief: Marlton Partners Comments On 180 Degree Capital Corp. And Mount Logan Capital Business Combination
Brief: 180 Degree Capital Corp. And Mount Logan Capital Inc. Announce Revised Terms Of Business Combination In Response To Constructive Conversations With Shareholders
Brief: 180 Degree Capital Corp. And Mount Logan Capital Inc. Provide Update On Proposed Business Combination
Brief: Marlton Partners Owns 5.2% Of 180 Degree Capital
Brief: 180 Degree Capital Says New Entity To Be Listed On Nasdaq As MLCI